Market Overview

Cell Viability Assays (MTT Assay, XTT Assay, Calcein, Resazurin, Flow Cytometry, Spectrophotometer) Market - Global Forecast to 2023 - ResearchAndMarkets.com

Share:

The "Cell
Viability Assays Market by Product (MTT Assay, XTT Assay, Calcein,
Resazurin, Flow Cytometry, Spectrophotometer), Cell Type (Human, Animal,
Microbial), Application (Basic Research, Stem Cell, Discovery &
Development) - Global Forecast to 2023"
report has been added
to ResearchAndMarkets.com's offering.

The cell viability assays market is expected to reach USD 4.16 billion
by 2023 from an estimated USD 2.78 billion in 2018, at a CAGR of 8.4%.

The rising incidence and prevalence of chronic and infectious diseases,
growing availability of funds for research and rising demand for
cell-based assays in research, and increasing focus on the development
of cell-based therapeutics are the key drivers for market growth.
However, the high cost of instruments is expected to restrain the growth
of this market to a certain extent during the forecast period.

On the basis of cell type, the cell viability assays market is segmented
into human cells, animal cells, and microbial cells. The human cells
segment is expected to register the highest CAGR during the forecast
period. Growth in this segment is mainly due to the growing investments
by government bodies and private sector organizations in research
activities that are focused on developing new treatments for various
human diseases.

On the basis of application, the cell viability assays market is
segmented into drug discovery & development, basic research, stem cell
research, clinical & diagnostic applications, and other applications.
The stem cell research applications segment is expected to witness the
highest CAGR owing to the increasing number of stem cell research
activities and rising investments in stem cell research.

North America is expected to account for the largest share of the global
cell viability assays market in 2018. On the other hand, the APAC region
is expected to witness the highest CAGR during the forecast period,
owing to the increasing prevalence of chronic and infectious diseases in
this region, large patient population, increasing healthcare spending,
and growing interest of key players in APAC countries.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Cell Viability Assays Market, By Product

7 Cell Viability Assays Market, By Cell Type

8 Cell Viability Assays Market, By Application

9 Cell Viability Assays Market, By End User

10 Cell Viability Assays Market, By Region

11 Competitive Landscape

12 Company Profiles

  • Abcam PLC
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Biotek Instruments
  • Biotium
  • Creative Bioarray
  • Danaher Corporation
  • GE Healthcare
  • Merck KGaA
  • Perkinelmer
  • Promega Corporation
  • Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/p9gc8p/cell_viability?w=4

View Comments and Join the Discussion!